Related Experiment Video

Updated: Jun 21, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Does the DRB1*1501 allele confer more severe and faster progression in primary progressive multiple sclerosis

Claudia Cristina Ferreira Vasconcelos1, Oscar Fernández, Laura Leyva

  • 1Federal University of the State of Rio de Janeiro, Rio de Janeiro, Brazil.

Journal of Neuroimmunology
|July 21, 2009
PubMed

Insights

This study found a link between specific HLA alleles, including DR2, DRB1*1501, and DQB1*0602, and primary progressive multiple sclerosis (PPMS). Certain HLA alleles were associated with more severe outcomes in PPMS patients.

Area of Science:

  • Immunogenetics
  • Neurology
  • Autoimmune Diseases

Background:

  • The human leukocyte antigen (HLA) system plays a crucial role in immune responses.
  • The association between HLA alleles and multiple sclerosis (MS) susceptibility and progression is complex and debated.
  • Conflicting results exist regarding the impact of specific HLA alleles on MS outcomes, necessitating further investigation.

Purpose of the Study:

  • To investigate the association between the HLA DR2 haplotype and primary progressive multiple sclerosis (PPMS).
  • To evaluate the effect of specific HLA alleles on disease progression and morbidity in PPMS patients.
  • To explore potential genetic factors contributing to the heterogeneity of MS disease course.

Main Methods:

  • Case-control study design.
  • Genotyping of HLA alleles, specifically focusing on the DR2 haplotype and related alleles (DRB1*1501, DQB1*0602).
  • Clinical data analysis to correlate HLA genotypes with disease progression and severity in PPMS patients.

Main Results:

  • A significant association was identified between PPMS and the HLA DR2 haplotype, including alleles DRB1*1501 and DQB1*0602.
  • Patients with PPMS who were positive for the DRB1*1501 allele exhibited more severe disease morbidity.
  • These findings suggest a specific role for certain HLA alleles in the clinical presentation of PPMS.

Conclusions:

  • The HLA DR2 haplotype, particularly DRB1*1501 and DQB1*0602, is associated with primary progressive multiple sclerosis.
  • The DRB1*1501 allele may be linked to increased disease severity in PPMS.
  • Further research is warranted to explore non-HLA genetic factors influencing MS heterogeneity and progression.

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Genetic Lingo01:11

Genetic Lingo

Overview
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...